Effectiveness of periodic incentives on clinic attendance and hepatitis C testing and treatment for people who inject drugs: A five-year retrospective program evaluation
Authors:
Open Access
- 9 June 2025
- journal article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 143, 104868
Abstract
No abstract availableKeywords
Funding Information
- NSW Health
This publication has 29 references indexed in Scilit:
- Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage studyInternational Journal of Drug Policy, 2024
- Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatmentDrug and Alcohol Dependence, 2022
- Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesisInternational Journal of Drug Policy, 2021
- Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs: A pilot studyInternational Journal of Drug Policy, 2019
- Strategies used by people who inject drugs to avoid stigma in healthcare settingsDrug and Alcohol Dependence, 2019
- Stigma at every turn: Health services experiences among people who inject drugsInternational Journal of Drug Policy, 2018
- Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in AustraliaInternational Journal of Drug Policy, 2017
- Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe ProgramsInternational Journal of Drug Policy, 2016
- Recommendations for the management of hepatitis C virus infection among people who inject drugsInternational Journal of Drug Policy, 2015
- Incentivizing HIV/STI Testing: A Systematic Review of the LiteratureAIDS and Behavior, 2013